Mosaic's 10-K/A filed March 17, 2026, covering the fiscal year ended December 31, 2025, delivered a full-year earnings picture that validated the bear case more precisely than any single quarterly print could. The actual full-year EPS of $1.70 per share against a consensus estimate of $0.49 — a figure that, in isolation, appears to represent a beat — requires immediate context: the $0.49 estimate applied to the Q4 slice, not the annual period, while management's SEC-reported full-year EPS of $1.70 reflects cumulative performance across four quarters of steadily deteriorating margin structure. Revenue of $2.974 billion for the period came in essentially at expectations, registering a -0.02% surprise, but that near-consensus revenue figure masks the more consequential story: Mosaic generated $12.052 billion in annual sales while producing a gross margin of only 15.78% and an operating margin of 6.82%, confirming that top-line scale is not translating into bottom-line resilience.
Print Scorecard
| Metric | Actual | Estimate | Surprise % | Source | Date |
| EPS (Q4 consensus basis) | $0.22 | $0.49 | -55.10% | 10-K/A, Benzinga estimate | 2026-03-17 |
|---|---|---|---|---|---|
| Revenue | $2.974B | ~$2.974B | -0.02% | 10-K/A | 2026-03-17 |
| Gross Margin | 15.78% | — | — | 10-K/A | 2026-03-17 |
| Operating Margin | 6.82% | — | — | 10-K/A | 2026-03-17 |
| Net Margin | 4.49% | — | — | 10-K/A | 2026-03-17 |
| Full-Year EPS (SEC reported) | $1.70 | — | — | 10-K/A | 2026-03-17 |
| Full-Year Revenue (SEC reported) | $12.052B | — | — | 10-K/A | 2026-03-17 |
The EPS surprise of -55.10% on the Q4 period estimate is the operative data point. Mosaic delivered $0.22 against a $0.49 consensus, a miss of $0.27 per share that is not attributable to revenue shortfall — the top line cleared — but rather to cost structure and margin erosion at every layer of the income statement.
Narrative Test
The prevailing narrative entering this print held that Mosaic's stock was statistically undervalued following a sharp decline tied to a large Q1 loss and the withdrawal of phosphate segment guidance. That narrative was neither confirmed nor cleanly broken — it was complicated in a structurally important way.
The undervaluation argument rests on traditional valuation metrics, and those metrics have not disappeared: a trailing P/E of 12.82 on a $6.9 billion market cap, and a reported fair value gap of -69.47%, do indicate the stock trades at a significant discount to estimated intrinsic value. That portion of the incoming narrative holds on paper.
What the print complicates is the premise underlying the recovery case. The exhausted-narrative classification — distributed sentiment, weakened guidance posture, a stock down 36.30% over the trailing 52 weeks — is now validated by the filing itself. Gross margin at 15.78% represents a thin buffer for a capital-intensive fertilizer producer facing input cost variability. An operating margin of 6.82% and net margin of 4.49% on $12 billion in revenue describes a business running at industrial-commodity economics with limited earnings leverage. The story that Mosaic is undervalued may be arithmetically accurate; the story that undervaluation implies near-term mean reversion is unsupported by the margin trajectory revealed in the 10-K/A.
Forensic Dissection
The EPS miss is the first-order finding, but the margin stack tells the more durable story. At 15.78%, gross margin is operating in territory that leaves Mosaic with minimal room to absorb freight, energy, or raw material cost increases without flowing directly to the operating line. The 6.82% operating margin implies that SG&A and overhead are consuming roughly 900 basis points of gross profit — substantial for a company whose competitive positioning depends on low-cost production scale.
Net margin of 4.49% on $12.052 billion in revenue produces net income in the range of $540 million for the full year. Against a $6.9 billion market cap, that arithmetic yields an earnings yield approaching 7.8%, which is the mathematical basis for the undervaluation argument. However, the directional signal from the filing — withdrawn phosphate guidance, Q1 loss large enough to define the prevailing narrative, and now a Q4 EPS print at less than half of consensus — suggests that the $1.70 full-year EPS should be read as a cyclical high-water mark under pressure rather than a stable earnings floor.
The revenue near-flat surprise (-0.02%) indicates that volume and pricing together held approximately where analysts expected for the period. The shortfall was entirely a cost and margin event, not a demand event. That distinction matters for segment diagnosis: if Mosaic is moving product at expected volumes and prices but cannot convert revenue to earnings at consensus rates, the compression is originating in the cost structure — energy inputs, sulfur, ammonia, or operational fixed cost absorption — rather than in a market share or pricing problem.
Watchlist — Next Quarter and Next 30 Days
- Phosphate segment guidance reinstatement: Management withdrew phosphate guidance following the Q1 loss. Any restoration of formal segment-level targets in the Q1 2026 earnings call (transcripts already circulating per May 11 headlines) will be the single highest-signal event for narrative stabilization.
- Input cost trajectory: Gross margin at 15.78% leaves negligible buffer. Sulfur, ammonia, and natural gas price movements over the next 30 days will determine whether Q1 2026 gross margin holds above the structural floor or deteriorates further.
- Short interest behavior: Short float at 7.66% is elevated but not extreme. A continued deterioration in margin guidance or a second consecutive large quarterly loss could accelerate short positioning; conversely, any cost relief could trigger covering pressure given the 52-week return of -36.30%.
- Full-year 2026 cost guidance specificity: The Q1 2026 earnings call highlights reference "navigating cost challenges." Investors should monitor whether management provides quantified cost reduction targets or maintains qualitative framing, as the latter would signal continued uncertainty in the operating cost structure.
Mosaic enters the 2026 reporting cycle with a margin structure that makes the undervaluation thesis arithmetically defensible but operationally contingent on a cost normalization that the company's own guidance withdrawal suggests management cannot yet forecast with confidence.